Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
SciTech Development Raises $2.73 Million in Oversubscribed Funding Round to Advance Clinical Trials for Cancer Treatment
SciTech Development has announced it has closed a $2.73M funding round, led by several prominent […]
TriLink BioTechnologies® Announces Manufacturing Capabilities Expansion as mRNA Manufacturing Facility Nears Completion
TriLink BioTechnologies, a Maravai LifeSciences company and global provider of life science reagents and services, […]
RQM+ Acquires Libra Medical
RQM+, the world’s leading MedTech service provider, has announced the acquisition of Libra Medical, a […]
FDA Issues Draft Guidance Aimed at Improving Oncology Clinical Trials for Accelerated Approval
The United States Food and Drug Administration (FDA) issued draft guidance, Clinical Trial Considerations to […]
ObvioHealth Announces Ground-Breaking Digital Therapeutics API to Capture More Accurate Efficacy and Adherence Data in Clinical Trials
ObvioHealth, a pioneering virtual research organization, announces the launch of a proprietary application programming interface […]
Vysioneer Announces Data Sharing Agreement with Pfizer to Augment Oncology Clinical Trials with Artificial Intelligence
Vysioneer, a pioneer in AI for Oncology, today announced a data-sharing agreement with Pfizer, a […]
OxSonics Announces First-in-human Clinical Data Shows SonoTran(R) is Safe and Well-tolerated
OxSonics Therapeutics, a clinical-stage medtech company focused on transforming cancer treatment through SonoTran, its proprietary […]
Huma to Provide Best-in-class Digital Clinical Trials Solutions Through Landmark Acquisition of Alcedis
Huma Therapeutics, a leading global digital health company, today announced that it has acquired Alcedis […]
Sustained Therapeutics Advancing Clinical Trial for Novel Drug Delivery Platform
A Vancouver-based therapeutics company, Sustained Therapeutics, has received regulatory approval to begin the second Phase […]
OnQuality Pharmaceuticals Expands Part 2 of the NOVA-II Phase 2 Clinical Trial to China and India
OnQuality Pharmaceuticals, a targeted oncology supportive therapy company developing innovative medications to address the quality […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more